| Aug 7 |
MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development Update
|
| Aug 6 |
MannKind Q2 Earnings Preview
|
| Jul 31 |
MannKind Launches Educational Website to Raise Awareness of NTM Lung Disease
|
| Jul 30 |
MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024
|
| Jul 23 |
MannKind Corporation: Finally Gaining Traction
|
| Jul 17 |
Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?
|
| Jul 16 |
All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy
|
| Jul 16 |
Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?
|
| Jul 16 |
MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?
|
| Jun 22 |
INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
|
